eptinezumab is in phase iii trials. its maker plans to submit an application with the fda later this year. it is for chronic migraine prevention..738, may 18, 2018 (eat),.
.
.
msnbc host chris hayes says that trump asked gates this twice: once at their meeting in 2017, and again at their meeting in 2018.